Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study;Prevalencia de fibrilación auricular en la población Española de 60 o más años de edad. Estudio PREV-ICTUS

Revista Espanola de Cardiologia

Volumn 60, Issue 6, 2007, Pages 616-624

  Cea Calvo, Luis ^a   Redón, Josep ^b,g   Lozano, José V ^c   Fernández Pérez, Cristina ^d   Martí Canales, Juan C ^e   Llisterri, José L ^c   González Esteban, Jorge ^a   Aznar, José ^f  

^a Medical affairs Merck sharp and Dohme ltd   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Centro de Salud Nazaret   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Centro de Salud San Antonio   (Spain)

^f HOSPITAL MARINA ALTA   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Atrial fibrillation; Cardiovascular disease; Population based studies; Prevalence; Systemic arterial hypertension

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; POPULATION RISK; PREVALENCE; RANDOM SAMPLE; RISK FACTOR; SITTING; SMOKING; SPAIN; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTICENTER STUDY;

AGED; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPAIN;

EID: 34347216039     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13107118     Document Type: Article

References (33)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236-41.
3. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N-9N.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
5. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018-22.
6. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA. 1981;245:1540-4.
7. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-64.
8. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14:666-72.
9. Candel FJ, Matesanz M, Cogolludo F, Candel I, Mora C, Bescos T, et al. Prevalencia de fibrilación auricular y factores relacionados en una población en el centro de Madrid. An Med Interna. 2004;21:477-82.
10. Masiaa R, Sala J, Marrugat J, Pena A, Investigadores del Estudio REGICOR. Prevalencia de fibrilación auricular en la provincia de Girona: el Estudio REGICOR. Rev Esp Cardiol. 2001;54:1240.
11. Labrador García MS, Merino Segovia R, Jiménez Domínguez C, García Salvador Y, Segura Fragoso A, Hernández Lanchas C. Prevalencia de fibrilación auricular en mayores de 65 años de una zona de salud. Aten Primaria. 2001;28:648-51.
12. García-Acuña JM, González-Juanatey JR, Alegría Ezquerra E, González Maqueda I, Listerri JL. La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol. 2002;55:943-52.
13. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J, et al. Blood pressure and estimated risk of stroke in the elderly population of Spain. The PREV-ICTUS Study. Stroke. 2007;38:1167-73.
14. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:13747.
15. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sexspecific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75:56572.
16. Sokolow M, Lyon T. Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:16186.
17. Instituto Nacional de Estadística. Cifras de población [accedido 1 Jul 2006]. Disponible en: http://www.ine.es/inebase/cgi/um?M= %2Ft20%2Fe260&O=inebase&N=&L=
18. Instituto de Demografía (1994), Proyección de la población española. Madrid, Instituto de Demografía/CSIC [accedido 1 Sept 2006]. Disponible en: http://www.ced.uab.es/publicacions/ PapersPDF/Text174.pdf.
19. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-25.
20. Tsang TS, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, Wiebers DO, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol. 2003;42:93-100.
21. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131:790-5.
22. Lake FR, Cullen KJ, De Klert NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med. 1989;19:321-6.
23. Heeringa J, Van der Kuip DA, Hofman A, Kors JA, Van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-53.
24. Greenlee RT, Vidaillet H. Recent progress in the epidemiology of atrial fibrillation. Curr Opin Cardiol. 2005;20:7-14.
25. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003;91(10A):9G-14G.
26. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension. 2003;41:218-23.
27. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712-9.
28. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-4.
29. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105:315-8.
30. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004;107:539-57.
31. Watson T, Lip GY. Blood pressure measurement in atrial fibrillation: goodbye mercury? J Hum Hypertens. 2006;20:638-40.
32. Stewart MJ, Gough K, Padfield PL. The accuracy of automated blood pressure measuring devices in patients with controlled atrial fibrillation. J Hypertens. 1995;13:297-300.
33. Jani B, Bulpitt CJ, Rajkumar C. Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens. 2006;20:543-5.